Depression in patients with cardiac disease:: a practical review

被引:198
作者
Lespérance, F
Frasure-Smith, N
机构
[1] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada
[2] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada
[3] McGill Univ, Dept Psychiat, Montreal, PQ, Canada
[4] McGill Univ, Sch Nursing, Montreal, PQ, Canada
关键词
depression; treatment; diagnosis; coronary artery disease; antidepressants;
D O I
10.1016/S0022-3999(99)00102-6
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Some degree of depression affects at least 30% of hospitalized patients with coronary artery disease (CAD), and is associated with increased risks of mortality and continuing depression over at least the first year following hospital discharge. Despite its consequences for prognosis and quality of life, depression is underrecognized and undertreated in cardiac patients. The diagnosis of depression is complicated in patients with medical illness. Their symptoms can reflect physical as well as psychological complaints. Many CAD patients resist the idea of additional medications, and drug interactions can be problematic for those willing to accept antidepressant treatment. Finally, depression tends to recur. Its successful treatment requires a long-term commitment from both physician and patient. This article examines the special challenges involved in diagnosing depression in patients with CAD. outlines available psychotherapeutic and pharmacological treatments, and considers the issues involved in deciding which patients to treat, with what approach, and for how long. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:379 / 391
页数:13
相关论文
共 113 条
  • [1] BIOBEHAVIORAL VARIABLES AND MORTALITY OR CARDIAC-ARREST IN THE CARDIAC-ARRHYTHMIA PILOT-STUDY (CAPS)
    AHERN, DK
    GORKIN, L
    ANDERSON, JL
    TIERNEY, C
    HALLSTROM, A
    EWART, C
    CAPONE, RJ
    SCHRON, E
    KORNFELD, D
    HERD, JA
    RICHARDSON, DW
    FOLLICK, MJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (01) : 59 - 62
  • [2] Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
  • [3] ANDRA R, 1993, EPIDEMIOLOGY, P285
  • [4] ANESHENSEL CS, 1982, ARCH GEN PSYCHIAT, V39, P1392
  • [5] DEPRESSION AND CARDIOVASCULAR-DISEASES
    AROMAA, A
    RAITASALO, R
    REUNANEN, A
    IMPIVAARA, O
    HELIOVAARA, M
    KNEKT, P
    LEHTINEN, V
    JOUKAMAA, M
    MAATELA, J
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 : 77 - 82
  • [6] INCREASED SEROTONIN2 (5-HT2) RECEPTOR-BINDING AS MEASURED BY H-3 LYSERGIC ACID DIETHYLAMIDE (H3-LSD) IN THE BLOOD-PLATELETS OF DEPRESSED-PATIENTS
    ARORA, RC
    MELTZER, HY
    [J]. LIFE SCIENCES, 1989, 44 (11) : 725 - 734
  • [7] Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
    Barefoot, JC
    Schroll, M
    [J]. CIRCULATION, 1996, 93 (11) : 1976 - 1980
  • [8] AN INVENTORY FOR MEASURING DEPRESSION
    BECK, AT
    ERBAUGH, J
    WARD, CH
    MOCK, J
    MENDELSOHN, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) : 561 - &
  • [9] Psychopharmacologic treatment of depression in the medically ill
    Beliles, K
    Stoudemire, A
    [J]. PSYCHOSOMATICS, 1998, 39 (03) : S2 - S19
  • [10] A REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR (MOCLOBEMIDE) FACILITATES SMOKING CESSATION AND ABSTINENCE IN HEAVY, DEPENDENT SMOKERS
    BERLIN, I
    SAID, S
    SPREUXVAROQUAUX, O
    LAUNAY, JM
    OLIVARES, R
    MILLET, V
    LECRUBIER, Y
    PUECH, AJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (04) : 444 - 452